 |
Respiratory syncytial virus immune globulin (Human) |
|---|---|
| Trade Name | Respigam |
| Orphan Indication | Prophylaxis of respiratory syncytial virus lower respiratory tract infections in infants and young children at high risk of RSV disease |
| USA Market Approval | USA |
| USA Designation Date | 1990-09-27 00:00:00 |
| Sponsor | MedImmune & Massachussetts Public Health Biologics Labs.;35 West Watkins Mill Road;Gaithersburg, Maryland, 20878 |
